Odinwell
Logotype for Odinwell

Odinwell (ODIN) investor relations material

Odinwell Q3 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Odinwell
Q3 2026 earnings summary17 Nov, 2026

Executive summary

  • Q3 focus shifted from product development toward commercialization, with novaQS veterinary launch targeted for Q4 2026 and two global wound-care actors evaluating the platform.

  • After quarter-end, one global wound-care actor provided a Letter of Intent and another began an additional evaluation collaboration; a new patent application was filed in November.

Financial highlights

  • Q3 2026 revenue was SEK 816k vs. SEK 988k YoY; operating loss was SEK 1.442m vs. SEK 1.501m, and net loss was SEK 1.442m vs. SEK 1.400m.

  • Q3 EPS was -SEK 0.02 vs. -SEK 0.04 YoY; 9M revenue was SEK 2.580m vs. SEK 3.079m, operating loss SEK 4.052m vs. SEK 4.971m, and net loss SEK 4.027m vs. SEK 4.807m.

  • 9M EPS was -SEK 0.05 vs. -SEK 0.12; cash and cash equivalents were SEK 2.957m at Sep. 30, 2026, vs. SEK 3.485m a year earlier.

Outlook and guidance

  • CE marking and launch of novaQS for the veterinary market remained targeted for Q4 2026; results from the horse study are expected to support product use and marketing.

  • Commercial focus is moving toward market entry, with further customer, distributor and strategic-partner discussions underway in Sweden and internationally.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Odinwell earnings date

Logotype for Odinwell
Q4 202625 Feb, 2027
Odinwell
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

Next Odinwell earnings date

Logotype for Odinwell
Q4 202625 Feb, 2027

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

Odinwell is a Swedish medtech company focused on revolutionizing the field of wound care through its patented optical technology. This innovative approach allows for the assessment of covered wounds without the need to remove dressings, thus enabling more accurate and timely treatments. Odinwell's technology is particularly designed to enhance medical solution providers' offerings by incorporating optical sensors into dressings. These sensors can detect a range of biomarkers such as signs of infection, blood, fluids, and pressure, facilitating real-time, non-invasive wound assessment. The company is headquartered in Halmstad, Sweden, and its shares are listed on the Stockholm Stock Exchange.